Medical Evidence Blog

This is discussion forum for physicians, researchers, and other healthcare professionals interested in the epistemology of medical knowledge, the limitations of the evidence, how clinical trials evidence is generated, disseminated, and incorporated into clinical practice, how the evidence should optimally be incorporated into practice, and what the value of the evidence is to science, individual patients, and society.

Showing posts with label opportunity costs. Show all posts
Showing posts with label opportunity costs. Show all posts
Wednesday, May 2, 2018

Hollow Hegemony: The Opportunity Costs of Overemphasizing Sepsis

›
Protocols are to make complex tasks simple, not simple tasks complex. - Scott K Aberegg Yet here we find ourselves some 16 years af...
Tuesday, February 3, 2009

Cost: The neglected adverse event / side effect in trials of for-profit pharmaceuticals and devices

›
Amid press releases and conference calls today pertaining to the release of data on two trials of the investigational drug pirfenidone, one ...
3 comments:
Monday, March 31, 2008

MRK and SGP: Ye shall know the truth, and the truth shall send thy stock spiralling

›
Apparently, the editors of the NEJM read my blog (even though they stop short of calling for a BOYCOTT): "...it seems prudent to encour...
7 comments:
›
Home
View web version

About Me

My photo
Scott K. Aberegg, M.D., M.P.H.
Professor of Medicine, University of Utah. Former affiliations: Outside Hospital x 7.5 years; Assistant Professor, The Ohio State University; Fellowship & MPH: Johns Hopkins Hospital & Bloomberg School of Public Health, Baltimore, MD; Residency: The University of New Mexico Health Sciences Center; MD: The Ohio State University; BA, Spanish: Miami University, Ohio. All views are my own with NO institutional endorsement.
View my complete profile
Powered by Blogger.